Glenmark Pharmaceuticals Ltd. | Balance Sheet
Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
8,175
7,789
8,583
10,577
16,203
Total Accounts Receivable
27,850
30,562
28,348
30,563
23,318
Inventories
11,601
14,882
17,993
24,187
20,306
Other Current Assets
-
-
4,138
3,419
10,060
Total Current Assets
47,627
53,233
59,061
68,746
69,887
Net Property, Plant & Equipment
17,628
20,569
24,623
27,451
32,081
Total Investments and Advances
348
442
282
243
548
Long-Term Note Receivable
189
185
-
-
-
Intangible Assets
13,331
12,715
15,027
13,335
15,103
Other Assets
-
-
294
430
389
Total Assets
86,336
96,875
111,026
125,120
130,210
ST Debt & Current Portion LT Debt
8,383
12,256
15,008
1,873
2,950
Accounts Payable
13,626
20,457
19,408
19,035
18,698
Income Tax Payable
969
926
733
268
284
Other Current Liabilities
6,514
3,475
4,869
5,862
10,946
Total Current Liabilities
29,492
37,113
40,018
27,039
32,879
Long-Term Debt
24,287
25,744
24,873
45,363
41,418
Deferred Taxes
5,142
6,933
9,073
11,914
12,202
Other Liabilities
521
1,219
770
327
26
Total Liabilities
56,370
66,874
68,327
75,730
74,323
Common Equity (Total)
29,833
30,003
42,702
49,394
55,891
Total Shareholders' Equity
29,833
30,003
42,702
49,394
55,891
Total Equity
29,966
30,001
42,699
49,390
55,887
Liabilities & Shareholders' Equity
86,336
96,875
111,026
125,120
130,210
Accumulated Minority Interest
133
2
3
4
4
About Glenmark Pharmaceuticals
View Profile
